The effect of bendroflumethiazide on total, ultrafiltrable and ionized calcium in serum in normocalcaemic renal stone formers and in hyperparathyroidism.
D000042:Absorption; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001539:Bendroflumethiazide / Q000008:administration & dosage; D001798:Blood Proteins; D002118:Calcium / Q000097:blood* / Q000652:urine; D003404:Creatinine / Q000097:blood / Q000652:urine; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000378:metabolism*; D006973:Hypertension / Q000378:metabolism; D007669:Kidney Calculi / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000097:blood; D013054:Spectrophotometry, Atomic; D013268:Stimulation, Chemical; D014462:Ultrafiltration
D001798:Blood Proteins; D010710:Phosphates; D001539:Bendroflumethiazide; D003404:Creatinine; D002118:Calcium